Sudarshan Chemical Industries Limited has informed the Exchange about Transcript
SUDARSCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Chemical shared the transcript of its July 29, 2025 earnings call held after the Q4 and FY25 audited results, which include the newly acquired Heubach (Clariant legacy) pigment business. As 'One Sudarshan,' the company now has 19 plants across 11 countries, 4,000+ customers, and combined turnover of about EUR 1 billion. FY25 consolidated sales rose to INR 3,346 crores (from INR 2,539 crores) with adjusted EBITDA of INR 402 crores (vs INR 316 crores); legacy Sudarshan Pigment grew 17% with 15.2% EBITDA margin. Management guided Heubach (acquired group) to deliver EUR 35 million EBITDA in FY26 and EUR 90-100 million in 3-4 years, with deleveraging to zero net debt in 3-4 years from the current INR 650 crores. The RIECO business was weak (revenue down 28% to INR 228 crores) but is under restructuring and expected to turn around in FY26.
Positive for shareholders as management has laid out a clear multi-year growth and deleveraging roadmap anchored on the Heubach integration, with Heubach EBITDA targeted to nearly triple within 3-4 years. Near-term focus on cost synergies, working capital normalisation, and the RIECO turnaround will be key milestones to watch.